ImmunOs conducting joint research with Merck in the USA
Schlieren/Rahway - ImmunOs Therapeutics is now working together with Merck & Co in the USA. The partners are conducting a clinical trial to investigate the tumor therapy IOS-1002 in combination with a therapy developed by Merck.
Methanology partners with Maersk for renewable methanol
Neuhausen - Methanology has launched a Series A financing round and agreed a strategic partnership with the global shipping firm Maersk. Methanology produces renewable methanol from natural enzymes using a bio-catalytic process.
Squirro agrees partnership with STX Next
Zurich/Poznań - Squirro and STX Next have entered in a strategic partnership. The two companies are joining forces to develop solutions in the area of Artificial Intelligence (AI).
Chicken feathers as the basis of more sustainable fuel cells
Zurich/Singapore - Researchers from the Swiss Federal Institute of Technology in Zurich and Nanyang Technological University Singapore have developed a membrane to make fuel cells more sustainable. This is made from keratin obtained from the waste product of chicken feathers.
Lakera launches security for generative AI in businesses
Zurich - With the Lakera Guard solution, Lakera is now offering developers the opportunity to immediately protect their business applications based on generative Artificial Intelligence (AI) against the threat of cyber-attacks. Lakera Guard empowers developers to activate the database, which has amassed just under 30 million attack data points, with a single line of code.
Xlife Sciences becomes main shareholder in 4D Lifetec
Cham/Zurich - Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs in 4D Lifetec AG. For 4D Lifetec, this investment opens up new opportunities in the use of Artificial Intelligence (AI) for the early detection of cancer.
Researchers reverse prostate cancer therapy resistance
Bellinzona - Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came about after the first evidence was obtained of a causal link between accumulation of immune cells and disease progression.
QL partners with Ginkgo Bioworks
Zurich/Boston - QL, an innovative supplier of food technology solutions, has entered into a strategic partnership with the US biotechnology firm Ginkgo Bioworks. The cooperation should form the basis for the production of high quality dairy proteins. It is hoped that this can ease the pressure on the dairy industry.
Nanoflex Robotics and Brainomix awarded grant for partnership
Zurich/Oxford - Nanoflex Robotics from the Greater Zurich Area and Brainomix, based in Oxford in the UK, are joining forces for the development of remote vascular interventions on stroke patients. To this end, Nanoflex Robotics will receive a sum of 400,000 Swiss francs from Innosuisse, with 400,000 pounds sterling awarded to Brainomix by Innovate UK.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.